Rognstad, Øyvind Bakken https://orcid.org/0009-0008-8498-5084
Botteri, Edoardo
Hoff, Geir
Bretthauer, Michael
Gulichsen, Elisabeth
Frigstad, Svein Oskar
Holme, Øyvind
Randel, Kristin Ranheim
Clinical trials referenced in this document:
Documents that mention this clinical trial
Detection of cancers and advanced adenomas in asymptomatic participants in colorectal cancer screening: a cross-sectional study (Results)
https://doi.org/10.1136/bmjopen-2020-048183
Use of claims data to identify adverse events after colonoscopy in a randomised colorectal cancer screening trial in Norway: a cross-sectional study
https://doi.org/10.1136/bmjopen-2025-109883
Adverse events after colonoscopy in a randomised colorectal cancer screening trial
https://doi.org/10.1136/bmjgast-2024-001471
Colonoscopy quality improvement after initial training: A cross-sectional study of intensive short-term training
https://doi.org/10.1055/a-1994-6084
Documents that mention this clinical trial
Detection of cancers and advanced adenomas in asymptomatic participants in colorectal cancer screening: a cross-sectional study (Results)
https://doi.org/10.1136/bmjopen-2020-048183
Use of claims data to identify adverse events after colonoscopy in a randomised colorectal cancer screening trial in Norway: a cross-sectional study
https://doi.org/10.1136/bmjopen-2025-109883
Adverse events after colonoscopy in a randomised colorectal cancer screening trial
https://doi.org/10.1136/bmjgast-2024-001471
Colonoscopy quality improvement after initial training: A cross-sectional study of intensive short-term training
https://doi.org/10.1055/a-1994-6084
Funding for this research was provided by:
Ferring pharmaceuticals (NA)
South-Eastern Norway Regional Health Authority (2020057)
Norwegian Parliament (NA)